{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:34:26Z","timestamp":1785764066822,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30670801"],"award-info":[{"award-number":["30670801"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Natural Science Foundation","doi-asserted-by":"crossref","award":["18YFZCSY00040"],"award-info":[{"award-number":["18YFZCSY00040"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Natural Science Foundation","doi-asserted-by":"crossref","award":["15JCYBJC26000"],"award-info":[{"award-number":["15JCYBJC26000"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key projects of Tianjin Municipal Education Commission","award":["2016YD01"],"award-info":[{"award-number":["2016YD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00262-019-02445-2","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T06:04:18Z","timestamp":1575439458000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-1848","authenticated-orcid":false,"given":"Chunyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2626-0938","authenticated-orcid":false,"given":"Yongrui","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9934-5775","authenticated-orcid":false,"given":"Yoichiro","family":"Iwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-2903","authenticated-orcid":false,"given":"Weimin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"2445_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","volume":"401","author":"Q Liu","year":"2017","unstructured":"Liu Q, Luo Q, HalimA Song G (2017) Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer. Cancer Lett 401:39\u201345","journal-title":"Cancer Lett"},{"key":"2445_CR2","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.bbalip.2013.02.010","volume":"1831","author":"KM Nieman","year":"2013","unstructured":"Nieman KM, Romero IL, HoutenB Van, Lengyel E (2013) Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 1831:1533\u20131541","journal-title":"Biochim Biophys Acta"},{"key":"2445_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17:1498\u20131503","journal-title":"Nat Med"},{"key":"2445_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA, Johnson A, Mitra AK, Sundaresan S, Nieman KM, Pascual G, Benitah SA, Montag A, Yamada SD, Abumrad NA, Lengyel E (2018) Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene 37:2285\u20132301","journal-title":"Oncogene"},{"key":"2445_CR5","doi-asserted-by":"publisher","first-page":"7801202","DOI":"10.1155\/2018\/7801202","volume":"2018","author":"AM Enciu","year":"2018","unstructured":"Enciu AM, Radu E, Popescu ID, Hinescu ME, Ceafalan LC (2018) Targeting CD36 as biomarker for metastasis prognostic: how far from translation into clinical practice? Biomed Res Int 2018:7801202","journal-title":"Biomed Res Int"},{"issue":"6","key":"2445_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/nu10060772","volume":"10","author":"N Sp","year":"2018","unstructured":"Sp N, Kang DY, Kim DH, Park JH, Lee HG, Kim HJ, Darvin P, Park YM, Yang YM (2018) Nobiletin inhibits CD36-dependent tumor angiogenesis, migration, invasion, and sphere formation through the Cd36\/Stat3\/Nf-kappab signaling axis. Nutrients 10(6):772\u2013786","journal-title":"Nutrients"},{"key":"2445_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-013-9274-4","volume":"15","author":"HL Kammoun","year":"2014","unstructured":"Kammoun HL, Kraakman MJ, Febbraio MA (2014) Adipose tissue inflammation in glucose metabolism. Rev Endocr Metab Disord 15:31\u201344","journal-title":"Rev Endocr Metab Disord"},{"key":"2445_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fphys.2013.00275","volume":"4","author":"V Catalan","year":"2013","unstructured":"Catalan V, Gomez-Ambrosi J, Rodriguez A, Fruhbeck G (2013) Adipose tissue immunity and cancer. Front Physiol 4:275","journal-title":"Front Physiol"},{"key":"2445_CR9","doi-asserted-by":"publisher","first-page":"5263974","DOI":"10.1155\/2017\/5263974","volume":"2017","author":"M Varas-Godoy","year":"2017","unstructured":"Varas-Godoy M, Rice G, Illanes SE (2017) The crosstalk between ovarian cancer stem cell niche and the tumor microenvironment. Stem Cells Int 2017:5263974","journal-title":"Stem Cells Int"},{"key":"2445_CR10","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.1038\/ncomms14649","volume":"8","author":"S Downs-Canner","year":"2017","unstructured":"Downs-Canner S, Berkey S, Delgoffe GM, Edwards RP, Curiel T, Odunsi K, Bartlett DL, Obermajer N (2017) Suppressive IL-17A(+)Foxp3(+) and ex-Th17 IL-17A(neg)Foxp3(+) Treg cells are a source of tumor-associated Treg cells. Nat Commun 8:14649","journal-title":"Nat Commun"},{"issue":"9","key":"2445_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/ijms17091433","volume":"17","author":"J Fabre","year":"2016","unstructured":"Fabre J, Giustiniani J, Garbar C, Antonicelli F, Merrouche Y, Bensussan A, Bagot M, Al-Dacak R (2016) Targeting the tumor microenvironment: the protumor effects of IL-17 related to cancer type. Int J Mol Sci 17(9):1433\u20131445","journal-title":"Int J Mol Sci"},{"key":"2445_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18632\/oncotarget.6646","volume":"7","author":"X Niu","year":"2016","unstructured":"Niu X, Liu W, Wang Y, Liu X, Zhang H, Li Z, Li H, Iwakura Y, Deng W (2016) IL-17A exacerbates cisplatin-based resistance of OVCA via upregulating the expression of ABCG2 and MDR1 through Gli1-mediated Hh signaling. Oncotarget 7:1\u201314","journal-title":"Oncotarget"},{"key":"2445_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/onc.2013.537","volume":"34","author":"T Xiang","year":"2015","unstructured":"Xiang T, Long H, He L, Han X, Lin K, Liang Z, Zhuo W, Xie R, Zhu B (2015) Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer. Oncogene 34:165\u2013176","journal-title":"Oncogene"},{"key":"2445_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"SB Coffelt","year":"2015","unstructured":"Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels L, Jonkers J, de Visser KE (2015) IL-17-producing gamma\u2013delta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522:345\u2013348","journal-title":"Nature"},{"key":"2445_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4161\/cbt.22955","volume":"14","author":"M Wang","year":"2013","unstructured":"Wang M, Wang L, Ren T, Xu L, Wen Z (2013) IL-17A\/IL-17RA interaction promoted metastasis of osteosarcoma cells. Cancer Biol Ther 14:155\u2013163","journal-title":"Cancer Biol Ther"},{"key":"2445_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2014.11.009","volume":"41","author":"K Wang","year":"2014","unstructured":"Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J, Zhang W, Zhong Z, Sanchez-Lopez E, Wu LW, Taniguchi K, Feng Y, Fearon E, Grivennikov SI, Karin M (2014) Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41:1052\u20131063","journal-title":"Immunity"},{"issue":"4","key":"2445_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1194\/jlr.S091793","volume":"60","author":"KJ Prentice","year":"2019","unstructured":"Prentice KJ, Saksi J, Hotamisligil GS (2019) Adipokine FABP4 integrates energy stores and counter regulatory metabolic responses. J Lipid Res 60(4):734\u2013740","journal-title":"J Lipid Res"},{"key":"2445_CR18","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.18632\/oncotarget.1482","volume":"4","author":"MK Herroon","year":"2013","unstructured":"Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, Podgorski I (2013) Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget 4:2108\u20132123","journal-title":"Oncotarget"},{"key":"2445_CR19","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/ijc.24112","volume":"124","author":"G Boiteux","year":"2009","unstructured":"Boiteux G, Lascombe I, Roche E, Plissonnier ML, Clairotte A, Bittard H, Fauconnet S (2009) A-FABP, a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells. Int J Cancer 124:1820\u20131828","journal-title":"Int J Cancer"},{"key":"2445_CR20","doi-asserted-by":"publisher","first-page":"23168","DOI":"10.1074\/jbc.M114.576512","volume":"289","author":"U Harjes","year":"2014","unstructured":"Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL (2014) Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. J Biol Chem 289:23168\u201323176","journal-title":"J Biol Chem"},{"key":"2445_CR21","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1038\/s41467-018-04987-y","volume":"9","author":"KM Gharpure","year":"2018","unstructured":"Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly K, La SE, Sood K (2018) FABP4 as a key determinant of metastatic potential of ovarian cancer. Nat Commun 9:2923","journal-title":"Nat Commun"},{"key":"2445_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5\u201329","journal-title":"CA Cancer J Clin"},{"key":"2445_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1152\/ajpcell.00188.2015","volume":"309","author":"TL Yeung","year":"2015","unstructured":"Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC (2015) Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis. Am J Physiol Cell Physiol 309:444\u2013456","journal-title":"Am J Physiol Cell Physiol"},{"key":"2445_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2017.00024","volume":"7","author":"T Worzfeld","year":"2017","unstructured":"Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, Muller R (2017) The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol 7:24","journal-title":"Front Oncol"},{"key":"2445_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","volume":"25","author":"LG Hudson","year":"2008","unstructured":"Hudson LG, Zeineldin R, Stack MS (2008) Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 25:643\u2013655","journal-title":"Clin Exp Metastasis"},{"key":"2445_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","volume":"377","author":"Z Luo","year":"2016","unstructured":"Luo Z, Wang Q, Lau WB, Lau B, Xu L, Zhao L, Yang H, Feng M, Xuan Y, Yang Y, Lei L, Wang C, Yi T, Zhao X, Wei Y, Zhou S (2016) Tumor microenvironment: the culprit for ovarian cancer metastasis? Cancer Lett 377:174\u2013182","journal-title":"Cancer Lett"},{"key":"2445_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4161\/cc.8.5.7703","volume":"8","author":"HA Kenny","year":"2009","unstructured":"Kenny HA, Lengyel E (2009) MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 8:683\u2013688","journal-title":"Cell Cycle"},{"key":"2445_CR28","doi-asserted-by":"crossref","first-page":"14 12 1","DOI":"10.1002\/0471141755.ph1412s45","volume":"45","author":"DC Connolly","year":"2009","unstructured":"Connolly DC, Hensley HH (2009) Xenograft and transgenic mouse models of epithelial ovarian cancer and non invasive imaging modalities to monitor ovarian tumor growth in situ\u2014applications in evaluating novel therapeutic agents. Curr Protoc Pharmacol 45:14 12 1\u201314 12 26","journal-title":"Curr Protoc Pharmacol"},{"key":"2445_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3892\/or.2017.5818","volume":"38","author":"N Liu","year":"2017","unstructured":"Liu N, Peng SM, Zhan GX, Yu J, Wu WM, Gao H, Li XF, Guo XQ (2017) Human chorionic gonadotropin beta regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer. Oncol Rep 38:1464\u20131472","journal-title":"Oncol Rep"},{"key":"2445_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1593\/neo.13952","volume":"15","author":"AV Nguyen","year":"2013","unstructured":"Nguyen AV, Wu YY, Liu Q, Wang D, Nguyen S, Loh R, Pang J, Friedman K, Orlofsky A, Augenlicht L, Pollard JW, Lin EY (2013) STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. Neoplasia 15:998\u20131008","journal-title":"Neoplasia"},{"key":"2445_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14:736\u2013746","journal-title":"Nat Rev Cancer"},{"key":"2445_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D, van der Windt GJ, Huang SC, Curtis JD, Chang CH, Buck MD, Qiu J, Smith AM, Lam WY, DiPlato LM, Hsu FF, Birnbaum MJ, Pearce EJ, Pearce EL (2014) Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41:75\u201388","journal-title":"Immunity"},{"key":"2445_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/CJI.0b013e31819302da","volume":"32","author":"T Inozume","year":"2009","unstructured":"Inozume T, Hanada K, Wang QJ, Yang JC (2009) IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells. J Immunother 32:109\u2013117","journal-title":"J Immunother"},{"key":"2445_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/CJI.0000000000000005","volume":"37","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhang Y, Liu Y, Wang L, Zhao L, Yang T, He C, Song Y, Gao Q (2014) Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients. J Immunother 37:43\u201350","journal-title":"J Immunother"},{"key":"2445_CR35","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1158\/1078-0432.CCR-14-0445","volume":"20","author":"SL Tucker","year":"2014","unstructured":"Tucker SL, Gharpure K, Herbrich SM, Unruh AK, Nick AM, Crane EK, Coleman RL, Guenthoer J, Dalton HJ, Wu SY, Rupaimoole R, Lopez-Berestein G, Ozpolat B, Ivan C, Hu W, Baggerly KA, Sood AK (2014) Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res 20:3280\u20133288","journal-title":"Clin Cancer Res"},{"key":"2445_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/oby.20954","volume":"23","author":"T Mita","year":"2015","unstructured":"Mita T, Furuhashi M, Hiramitsu S, Ishii J, Hoshina K, Ishimura S, Fuseya T, Watanabe Y, Tanaka M, Ohno K, Akasaka H, Ohnishi H, Yoshida H, Saitoh S, Shimamoto K, Miura T (2015) FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms. Obesity (Silver Spring) 23:359\u2013367","journal-title":"Obesity (Silver Spring)"},{"key":"2445_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ijo.2008.216","volume":"33","author":"M Sumarac-Dumanovic","year":"2009","unstructured":"Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, Trajkovic V, Micic D (2009) Increased activity of interleukin-23\/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 33:151\u2013156","journal-title":"Int J Obes (Lond)"}],"updated-by":[{"DOI":"10.1007\/s00262-023-03415-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000}}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-019-02445-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02445-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:30:40Z","timestamp":1695486640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-019-02445-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02445-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00262-023-03415-5","asserted-by":"object"}]},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"27 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00262-023-03415-5","URL":"https:\/\/doi.org\/10.1007\/s00262-023-03415-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Tianjin Central Hospital of Gynecology Obstetrics and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Ethical approval number 2017KY009). All experiments with C57BL\/6 mice were performed in compliance with the principles and procedures approved by the Animal Ethical and Welfare Committee (AEWC) of Tianjin Medical University (Protocol number SYXK 2016-0012).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and ethical standards"}},{"value":"Informed oral consent was obtained from all individual participants included in the study. Patients consented to the use of their tumor material and clinical data for research and publication. Healthy donors also consented to the use of their tissue for research and publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"C57BL\/6 wild-type (WT) mice were purchased from the Laboratory Animal Center of the Academy of Military Medical Sciences (Beijing, China). IL-17A<sup>\u2212\/\u2212<\/sup> C57BL\/6 mice were kindly provided by Hong Zhou (Nanjing Medical University, China) with permission from Yoichiro Iwakura (Tokyo University of Science, Chiba, Japan).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal source"}},{"value":"Authentication is not applicable since the human OvCa cell line A2780 was purchased from KeyGEN BioTECH (Cat# KG039, Nanjing, China), OVCAR3 and SKOV3 cells were gifts from Zhi Yao (Tianjin Medical University, Tianjin, China), and the mouse ovarian epithelial papillary serous adenocarcinoma cell line ID8 was a gift from Luyuan Li (Nankai University, Tianjin, China). Hence, no authentication information was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Cell line authentication"}}]}}